Patents by Inventor Jasmine Kaur

Jasmine Kaur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FUNCTIONAL LIGANDS
    Publication number: 20240110237
    Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules.
    Type: Application
    Filed: July 28, 2023
    Publication date: April 4, 2024
    Inventors: Jasmine Kaur, Rafal Drabek, George W. Jackson, Robert Batchelor, Alexander Chiu
  • Functional ligands to opioids and opioid derivatives
    Patent number: 11725240
    Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as opioids and opioid derivatives.
    Type: Grant
    Filed: January 19, 2021
    Date of Patent: August 15, 2023
    Assignee: BASE PAIR BIOTECHNOLOGIES, INC.
    Inventors: Jasmine Kaur, Rafal Drabek, George W. Jackson, Robert Batchelor, Alexander Chiu
  • FUNCTIONAL LIGANDS TO OPIOIDS AND OPIOID DERIVATIVES
    Publication number: 20210348226
    Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as opioids and opioid derivatives.
    Type: Application
    Filed: January 19, 2021
    Publication date: November 11, 2021
    Inventors: Jasmine Kaur, Rafal Drabek, George W. Jackson, Robert Batchelor, Alexander Chiu
  • FUNCTIONAL LIGANDS TO OPIOIDS AND OPIOID METABOLITES
    Publication number: 20210041470
    Abstract: The present invention relates functional ligands to target molecules, particularly to functional nucleic acids and modifications thereof, and to methods for simultaneously generating, for example, numerous different functional biomolecules, particularly to methods for generating numerous different functional nucleic acids against multiple target molecules simultaneously. The present invention further relates to functional ligands which bind with affinity to target molecules, such as opioids and opioid metabolites.
    Type: Application
    Filed: March 27, 2020
    Publication date: February 11, 2021
    Inventors: Jasmine Kaur, Rafal Drabek, George W. Jackson, Robert Batchelor
  • MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV
    Publication number: 20180263985
    Abstract: Provided are methods, uses, pharmaceutical regimens, pharmaceutical compositions, and kits comprising modulators of TLR8 and pharmaceutically acceptable salts thereof, useful in treating HIV infections.
    Type: Application
    Filed: September 13, 2016
    Publication date: September 20, 2018
    Inventors: ROMAS GELEZIUNAS, JOSEPH E. HESSELGESSER, JASMINE KAUR, JEFFREY PATRICK MURRY, DEREK DEAN SLOAN
  • MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV
    Publication number: 20170071944
    Abstract: Provided are methods, uses, pharmaceutical regimens, pharmaceutical compositions, and kits comprising modulators of TLR8 and pharmaceutically acceptable salts thereof, useful in treating HIV infections.
    Type: Application
    Filed: September 13, 2016
    Publication date: March 16, 2017
    Inventors: ROMAS GELEZIUNAS, Joseph E. Hesselgesser, Jasmine Kaur, Jeffrey Patrick Murry, Derek Dean Sloan
  • Preparation of Negative-Stranded RNA Viruses By Electroporation
    Publication number: 20130065309
    Abstract: The present invention encompasses methods of preparing non-segmented negative-stranded RNA viruses from cells utilizing electroporation.
    Type: Application
    Filed: September 13, 2012
    Publication date: March 14, 2013
    Applicant: MedImmune, LLC
    Inventors: Jeanne Schickli, Jasmine Kaur, Roderick Tang
  • Preparation of Negative-Stranded RNA Viruses by Electroporation
    Publication number: 20090017517
    Abstract: The present invention encompasses methods of preparing non-segmented negative-stranded RNA viruses from cells utilizing electroporation.
    Type: Application
    Filed: July 11, 2008
    Publication date: January 15, 2009
    Applicant: MedImmune, LLC
    Inventors: Jeanne Schickli, Jasmine Kaur, Roderick Tang